1 Daclatasvir Market Overview 1.1 Daclatasvir Product Overview 1.2 Daclatasvir Market Segment by Type 1.2.1 30mg Tables 1.2.2 60mg Tables 1.3 Global Daclatasvir Market Size by Type 1.3.1 Global Daclatasvir Market Size Overview by Type (2016-2027) 1.3.2 Global Daclatasvir Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Daclatasvir Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Daclatasvir Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Daclatasvir Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Daclatasvir Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Daclatasvir Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Daclatasvir Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Daclatasvir Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Daclatasvir Sales Breakdown by Type (2016-2021) 1.4.2 Europe Daclatasvir Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Daclatasvir Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Daclatasvir Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Daclatasvir Sales Breakdown by Type (2016-2021) 2 Global Daclatasvir Market Competition by Company 2.1 Global Top Players by Daclatasvir Sales (2016-2021) 2.2 Global Top Players by Daclatasvir Revenue (2016-2021) 2.3 Global Top Players Daclatasvir Price (2016-2021) 2.4 Global Top Manufacturers Daclatasvir Manufacturing Base Distribution, Sales Area, Product Type 2.5 Daclatasvir Market Competitive Situation and Trends 2.5.1 Daclatasvir Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Daclatasvir Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daclatasvir as of 2020) 2.7 Date of Key Manufacturers Enter into Daclatasvir Market 2.8 Key Manufacturers Daclatasvir Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Daclatasvir Status and Outlook by Region 3.1 Global Daclatasvir Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Daclatasvir Historic Market Size by Region 3.2.1 Global Daclatasvir Sales in Volume by Region (2016-2021) 3.2.2 Global Daclatasvir Sales in Value by Region (2016-2021) 3.2.3 Global Daclatasvir Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Daclatasvir Forecasted Market Size by Region 3.3.1 Global Daclatasvir Sales in Volume by Region (2022-2027) 3.3.2 Global Daclatasvir Sales in Value by Region (2022-2027) 3.3.3 Global Daclatasvir Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Daclatasvir by Application 4.1 Daclatasvir Market Segment by Application 4.1.1 Hepatitis C Virus (HCV) Genotype 1 4.1.2 Hepatitis C Virus (HCV) Genotype 3 4.1.3 Hepatitis C Virus (HCV) Genotype 4 4.2 Global Daclatasvir Market Size by Application 4.2.1 Global Daclatasvir Market Size Overview by Application (2016-2027) 4.2.2 Global Daclatasvir Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Daclatasvir Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Daclatasvir Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Daclatasvir Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Daclatasvir Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Daclatasvir Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Daclatasvir Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Daclatasvir Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Daclatasvir Sales Breakdown by Application (2016-2021) 4.3.2 Europe Daclatasvir Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Daclatasvir Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Daclatasvir Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Daclatasvir Sales Breakdown by Application (2016-2021) 5 North America Daclatasvir by Country 5.1 North America Daclatasvir Historic Market Size by Country 5.1.1 North America Daclatasvir Sales in Volume by Country (2016-2021) 5.1.2 North America Daclatasvir Sales in Value by Country (2016-2021) 5.2 North America Daclatasvir Forecasted Market Size by Country 5.2.1 North America Daclatasvir Sales in Volume by Country (2022-2027) 5.2.2 North America Daclatasvir Sales in Value by Country (2022-2027) 6 Europe Daclatasvir by Country 6.1 Europe Daclatasvir Historic Market Size by Country 6.1.1 Europe Daclatasvir Sales in Volume by Country (2016-2021) 6.1.2 Europe Daclatasvir Sales in Value by Country (2016-2021) 6.2 Europe Daclatasvir Forecasted Market Size by Country 6.2.1 Europe Daclatasvir Sales in Volume by Country (2022-2027) 6.2.2 Europe Daclatasvir Sales in Value by Country (2022-2027) 7 Asia-Pacific Daclatasvir by Region 7.1 Asia-Pacific Daclatasvir Historic Market Size by Region 7.1.1 Asia-Pacific Daclatasvir Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Daclatasvir Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Daclatasvir Forecasted Market Size by Region 7.2.1 Asia-Pacific Daclatasvir Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Daclatasvir Sales in Value by Region (2022-2027) 8 Latin America Daclatasvir by Country 8.1 Latin America Daclatasvir Historic Market Size by Country 8.1.1 Latin America Daclatasvir Sales in Volume by Country (2016-2021) 8.1.2 Latin America Daclatasvir Sales in Value by Country (2016-2021) 8.2 Latin America Daclatasvir Forecasted Market Size by Country 8.2.1 Latin America Daclatasvir Sales in Volume by Country (2022-2027) 8.2.2 Latin America Daclatasvir Sales in Value by Country (2022-2027) 9 Middle East and Africa Daclatasvir by Country 9.1 Middle East and Africa Daclatasvir Historic Market Size by Country 9.1.1 Middle East and Africa Daclatasvir Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Daclatasvir Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Daclatasvir Forecasted Market Size by Country 9.2.1 Middle East and Africa Daclatasvir Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Daclatasvir Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Daclatasvir Business 10.1 Bristol-Myers Squibb 10.1.1 Bristol-Myers Squibb Corporation Information 10.1.2 Bristol-Myers Squibb Introduction and Business Overview 10.1.3 Bristol-Myers Squibb Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Bristol-Myers Squibb Daclatasvir Products Offered 10.1.5 Bristol-Myers Squibb Recent Development 10.2 Natco Pharma 10.2.1 Natco Pharma Corporation Information 10.2.2 Natco Pharma Introduction and Business Overview 10.2.3 Natco Pharma Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Bristol-Myers Squibb Daclatasvir Products Offered 10.2.5 Natco Pharma Recent Development 10.3 Zydus Cadila 10.3.1 Zydus Cadila Corporation Information 10.3.2 Zydus Cadila Introduction and Business Overview 10.3.3 Zydus Cadila Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Zydus Cadila Daclatasvir Products Offered 10.3.5 Zydus Cadila Recent Development 10.4 Hetero Drugs 10.4.1 Hetero Drugs Corporation Information 10.4.2 Hetero Drugs Introduction and Business Overview 10.4.3 Hetero Drugs Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Hetero Drugs Daclatasvir Products Offered 10.4.5 Hetero Drugs Recent Development 10.5 Dr Reddy's Laboratories 10.5.1 Dr Reddy's Laboratories Corporation Information 10.5.2 Dr Reddy's Laboratories Introduction and Business Overview 10.5.3 Dr Reddy's Laboratories Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Dr Reddy's Laboratories Daclatasvir Products Offered 10.5.5 Dr Reddy's Laboratories Recent Development 10.6 Cipla 10.6.1 Cipla Corporation Information 10.6.2 Cipla Introduction and Business Overview 10.6.3 Cipla Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Cipla Daclatasvir Products Offered 10.6.5 Cipla Recent Development 10.7 Mylan 10.7.1 Mylan Corporation Information 10.7.2 Mylan Introduction and Business Overview 10.7.3 Mylan Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Mylan Daclatasvir Products Offered 10.7.5 Mylan Recent Development 10.8 Abbott 10.8.1 Abbott Corporation Information 10.8.2 Abbott Introduction and Business Overview 10.8.3 Abbott Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Abbott Daclatasvir Products Offered 10.8.5 Abbott Recent Development 10.9 Emcure Pharmaceuticals 10.9.1 Emcure Pharmaceuticals Corporation Information 10.9.2 Emcure Pharmaceuticals Introduction and Business Overview 10.9.3 Emcure Pharmaceuticals Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Emcure Pharmaceuticals Daclatasvir Products Offered 10.9.5 Emcure Pharmaceuticals Recent Development 10.10 Torrent Pharmaceuticals 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Daclatasvir Product Category, Application and Specification 10.10.3 Torrent Pharmaceuticals Daclatasvir Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 Torrent Pharmaceuticals Recent Development 10.11 Biocon 10.11.1 Biocon Corporation Information 10.11.2 Biocon Introduction and Business Overview 10.11.3 Biocon Daclatasvir Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Biocon Daclatasvir Products Offered 10.11.5 Biocon Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Daclatasvir Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Daclatasvir Industrial Chain Analysis 11.4 Daclatasvir Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Daclatasvir Distributors 12.3 Daclatasvir Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 30mg Tables Table 2. Major Company of 60mg Tables Table 3. Global Daclatasvir Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Daclatasvir Sales by Type (2016-2021) & (K Pcs) Table 5. Global Daclatasvir Sales Market Share in Volume by Type (2016-2021) Table 6. Global Daclatasvir Sales by Type (2016-2021) & (US& Million) Table 7. Global Daclatasvir Market Share in Value by Type (2016-2021) Table 8. Global Daclatasvir Price by Type (2016-2021) & (USD/Pcs) Table 9. Global Daclatasvir Sales by Type (2022-2027) & (K Pcs) Table 10. Global Daclatasvir Sales Market Share in Volume by Type (2022-2027) Table 11. Global Daclatasvir Sales by Type (2022-2027) & (US$ Million) Table 12. Global Daclatasvir Sales Market Share in Value by Type (2022-2027) Table 13. Global Daclatasvir Price by Type (2022-2027) & (USD/Pcs) Table 14. North America Daclatasvir Sales by Type (2016-2021) & (K Pcs) Table 15. North America Daclatasvir Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Daclatasvir Sales (K Pcs) by Type (2016-2021) Table 17. Europe Daclatasvir Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Daclatasvir Sales (K Pcs) by Type (2016-2021) Table 19. Asia-Pacific Daclatasvir Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Daclatasvir Sales (K Pcs) by Type (2016-2021) Table 21. Latin America Daclatasvir Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Daclatasvir Sales (K Pcs) by Type (2016-2021) Table 23. Middle East and Africa Daclatasvir Sales by Type (2016-2021) & (US$ Million) Table 24. Global Daclatasvir Sales by Company (2016-2021) & (K Pcs) Table 25. Global Daclatasvir Sales Share by Company (2016-2021) Table 26. Global Daclatasvir Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Daclatasvir Revenue Share by Company (2016-2021) Table 28. Global Market Daclatasvir Price by Company (2016-2021) & (USD/Pcs) Table 29. Global Daclatasvir Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Daclatasvir Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daclatasvir as of 2020 Table 32. Date of Key Manufacturers Enter into Daclatasvir Market Table 33. Key Manufacturers Daclatasvir Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Daclatasvir Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Daclatasvir Sales by Region (2016-2021) & (K Pcs) Table 37. Global Daclatasvir Sales Market Share in Volume by Region (2016-2021) Table 38. Global Daclatasvir Sales by Region (2016-2021) & (US$ Million) Table 39. Global Daclatasvir Sales Market Share in Value by Region (2016-2021) Table 40. Global Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 41. Global Daclatasvir Sales by Region (2022-2027) & (K Pcs) Table 42. Global Daclatasvir Sales Market Share in Volume by Region (2022-2027) Table 43. Global Daclatasvir Sales by Region (2022-2027) & (US$ Million) Table 44. Global Daclatasvir Sales Market Share in Value by Region (2022-2027) Table 45. Global Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 46. Global Daclatasvir Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Daclatasvir Sales by Application (2016-2021) & (K Pcs) Table 48. Global Daclatasvir Sales Market Share in Volume by Application (2016-2021) Table 49. Global Daclatasvir Sales by Application (2016-2021) & (US$ Million) Table 50. Global Daclatasvir Sales Market Share in Value by Application (2016-2021) Table 51. Global Daclatasvir Price by Application (2016-2021) & (USD/Pcs) Table 52. Global Daclatasvir Sales by Application (2022-2027) & (K Pcs) Table 53. Global Daclatasvir Sales Market Share in Volume by Application (2022-2027) Table 54. Global Daclatasvir Sales by Application (2022-2027) & (US$ Million) Table 55. Global Daclatasvir Sales Market Share in Value by Application (2022-2027) Table 56. Global Daclatasvir Price by Application (2022-2027) & (USD/Pcs) Table 57. North America Daclatasvir Sales by Application (2016-2021) (K Pcs) Table 58. North America Daclatasvir Sales by Application (2016-2021) & (US$ Million) Table 59. North America Daclatasvir Sales Market Share in Value by Application in 2020 Table 60. Europe Daclatasvir Sales by Application (2016-2021) (K Pcs) Table 61. Europe Daclatasvir Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Daclatasvir Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Daclatasvir Sales by Application (2016-2021) (K Pcs) Table 64. Asia-Pacific Daclatasvir Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Daclatasvir Sales Market Share in Value by Application in 2020 Table 66. Latin America Daclatasvir Sales by Application (2016-2021) (K Pcs) Table 67. Latin America Daclatasvir Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Daclatasvir Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Daclatasvir Sales by Application (2016-2021) (K Pcs) Table 70. Middle East and Africa Daclatasvir Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Daclatasvir Sales Market Share in Value by Application in 2020 Table 72. North America Daclatasvir Sales by Country (2016-2021) & (K Pcs) Table 73. North America Daclatasvir Sales Market Share in Volume by Country (2016-2021) Table 74. North America Daclatasvir Sales by Country (2016-2021) & (US$ Million) Table 75. North America Daclatasvir Sales Market Share in Value by Country (2016-2021) Table 76. North America Daclatasvir Sales by Country (2022-2027) & (K Pcs) Table 77. North America Daclatasvir Sales Market Share in Volume by Country (2022-2027) Table 78. North America Daclatasvir Sales by Country (2022-2027) & (US$ Million) Table 79. North America Daclatasvir Sales Market Share in Value by Country (2022-2027) Table 80. Europe Daclatasvir Sales by Country (2016-2021) & (K Pcs) Table 81. Europe Daclatasvir Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Daclatasvir Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Daclatasvir Sales Market Share in Value by Country (2016-2021) Table 84. Europe Daclatasvir Sales by Country (2022-2027) & (K Pcs) Table 85. Europe Daclatasvir Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Daclatasvir Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Daclatasvir Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Daclatasvir Sales by Region (2016-2021) & (K Pcs) Table 89. Asia-Pacific Daclatasvir Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Daclatasvir Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Daclatasvir Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Daclatasvir Sales by Region (2022-2027) & (K Pcs) Table 93. Asia-Pacific Daclatasvir Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Daclatasvir Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Daclatasvir Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Daclatasvir Sales by Country (2016-2021) & (K Pcs) Table 97. Latin America Daclatasvir Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Daclatasvir Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Daclatasvir Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Daclatasvir Sales by Country (2022-2027) & (K Pcs) Table 101. Latin America Daclatasvir Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Daclatasvir Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Daclatasvir Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Daclatasvir Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Daclatasvir Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Daclatasvir Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Daclatasvir Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Daclatasvir Sales by Country (2022-2027) & (K Pcs) Table 109. Middle East and Africa Daclatasvir Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Daclatasvir Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Daclatasvir Sales Market Share in Value by Country (2022-2027) Table 112. Bristol-Myers Squibb Corporation Information Table 113. Bristol-Myers Squibb Introduction and Business Overview Table 114. Bristol-Myers Squibb Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. Bristol-Myers Squibb Daclatasvir Product Table 116. Bristol-Myers Squibb Recent Development Table 117. Natco Pharma Corporation Information Table 118. Natco Pharma Introduction and Business Overview Table 119. Natco Pharma Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 120. Natco Pharma Daclatasvir Product Table 121. Natco Pharma Recent Development Table 122. Zydus Cadila Corporation Information Table 123. Zydus Cadila Introduction and Business Overview Table 124. Zydus Cadila Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 125. Zydus Cadila Daclatasvir Product Table 126. Zydus Cadila Recent Development Table 127. Hetero Drugs Corporation Information Table 128. Hetero Drugs Introduction and Business Overview Table 129. Hetero Drugs Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 130. Hetero Drugs Daclatasvir Product Table 131. Hetero Drugs Recent Development Table 132. Dr Reddy's Laboratories Corporation Information Table 133. Dr Reddy's Laboratories Introduction and Business Overview Table 134. Dr Reddy's Laboratories Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 135. Dr Reddy's Laboratories Daclatasvir Product Table 136. Dr Reddy's Laboratories Recent Development Table 137. Cipla Corporation Information Table 138. Cipla Introduction and Business Overview Table 139. Cipla Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 140. Cipla Daclatasvir Product Table 141. Cipla Recent Development Table 142. Mylan Corporation Information Table 143. Mylan Introduction and Business Overview Table 144. Mylan Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 145. Mylan Daclatasvir Product Table 146. Mylan Recent Development Table 147. Abbott Corporation Information Table 148. Abbott Introduction and Business Overview Table 149. Abbott Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 150. Abbott Daclatasvir Product Table 151. Abbott Recent Development Table 152. Emcure Pharmaceuticals Corporation Information Table 153. Emcure Pharmaceuticals Introduction and Business Overview Table 154. Emcure Pharmaceuticals Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 155. Emcure Pharmaceuticals Daclatasvir Product Table 156. Emcure Pharmaceuticals Recent Development Table 157. Torrent Pharmaceuticals Corporation Information Table 158. Torrent Pharmaceuticals Introduction and Business Overview Table 159. Torrent Pharmaceuticals Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 160. Torrent Pharmaceuticals Daclatasvir Product Table 161. Torrent Pharmaceuticals Recent Development Table 162. Biocon Corporation Information Table 163. Biocon Introduction and Business Overview Table 164. Biocon Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 165. Biocon Daclatasvir Product Table 166. Biocon Recent Development Table 167. Key Raw Materials Lists Table 168. Raw Materials Key Suppliers Lists Table 169. Daclatasvir Market Trends Table 170. Daclatasvir Market Drivers Table 171. Daclatasvir Market Challenges Table 172. Daclatasvir Market Restraints Table 173. Daclatasvir Distributors List Table 174. Daclatasvir Downstream Customers Table 175. Research Programs/Design for This Report Table 176. Key Data Information from Secondary Sources Table 177. Key Data Information from Primary Sources List of Figures Figure 1. Daclatasvir Product Picture Figure 2. Global Daclatasvir Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Daclatasvir Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Daclatasvir Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 30mg Tables Figure 6. Global 30mg Tables Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 60mg Tables Figure 8. Global 60mg Tables Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Global Daclatasvir Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Daclatasvir Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Daclatasvir Sales Market Share in Value by Type (2016-2021) Figure 12. Global Daclatasvir Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Daclatasvir Sales Market Share in Value by Type (2022-2027) Figure 14. North America Daclatasvir Sales Market Share in Volume by Type in 2020 Figure 15. North America Daclatasvir Sales Market Share in Value by Type in 2020 Figure 16. Europe Daclatasvir Sales Market Share in Volume by Type in 2020 Figure 17. Europe Daclatasvir Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Daclatasvir Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Daclatasvir Sales Market Share in Value by Type in 2020 Figure 20. Latin America Daclatasvir Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Daclatasvir Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Daclatasvir Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Daclatasvir Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Daclatasvir Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Daclatasvir Revenue in 2020 Figure 26. Daclatasvir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Hepatitis C Virus (HCV) Genotype 1 Figure 28. Global Hepatitis C Virus (HCV) Genotype 1 Sales YoY Growth (2016-2027) & (K Pcs) Figure 29. Product Picture of Hepatitis C Virus (HCV) Genotype 3 Figure 30. Global Hepatitis C Virus (HCV) Genotype 3 Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Product Picture of Hepatitis C Virus (HCV) Genotype 4 Figure 32. Global Hepatitis C Virus (HCV) Genotype 4 Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Global Daclatasvir Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Daclatasvir Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Daclatasvir Sales Market Share in Value by Application (2016-2021) Figure 36. Global Daclatasvir Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Daclatasvir Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Daclatasvir Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Daclatasvir Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Daclatasvir Manufacturing Cost Structure Figure 42. Daclatasvir Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Bristol-Myers Squibb Natco Pharma Zydus Cadila Hetero Drugs Dr Reddy's Laboratories Cipla Mylan Abbott Emcure Pharmaceuticals Torrent Pharmaceuticals Biocon